These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9555800)

  • 21. No increased risk of Kaposi sarcoma relapse in patients with controlled HIV-1 infection after switching protease inhibitor-based antiretroviral therapy.
    Lajaunie R; Cuzin L; Palich R; Makinson A; Bani-Sadr F; Duvivier C; Arvieux C; Rey D; Poizot-Martin I; Delpierre C; Delobel P; Martin-Blondel G;
    HIV Med; 2022 Mar; 23(3):301-306. PubMed ID: 34668293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
    de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
    J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential impact of combination antiretroviral therapy in preventing Kaposi's sarcoma with and without visceral involvement.
    Grabar S; Abraham B; Mahamat A; Del Giudice P; Rosenthal E; Costagliola D
    J Clin Oncol; 2006 Jul; 24(21):3408-14. PubMed ID: 16849755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiretroviral Therapy for HIV-Associated Cutaneous Kaposi's Sarcoma: Clinical, HIV-Related, and Sociodemographic Predictors of Outcome.
    Ngalamika O; Munsaka S; Lidenge SJ; West JT; Wood C
    AIDS Res Hum Retroviruses; 2021 May; 37(5):368-372. PubMed ID: 33386064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of a randomized study of IM862 nasal solution in the treatment of AIDS-related Kaposi's sarcoma.
    Tulpule A; Scadden DT; Espina BM; Cabriales S; Howard W; Shea K; Gill PS
    J Clin Oncol; 2000 Feb; 18(4):716-23. PubMed ID: 10673512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regression of AIDS-related Kaposi's sarcoma following ritonavir therapy.
    Diz Dios P; Ocampo Hermida A; Miralles Alvarez C; Vázquez García E; Martínez Vázquez C
    Oral Oncol; 1998 May; 34(3):236-8. PubMed ID: 9692061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Protease Inhibitors on HIV-Associated Kaposi Sarcoma Incidence: A Systematic Review.
    Chang E; Mapakshi SR; Mbang P; El-Mallawany NK; Kramer JR; White DL; Chiao EY
    J Acquir Immune Defic Syndr; 2018 Oct; 79(2):141-148. PubMed ID: 29985803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pilot study evaluating the interaction between paclitaxel and protease inhibitors in patients with human immunodeficiency virus-associated Kaposi's sarcoma: an Eastern Cooperative Oncology Group (ECOG) and AIDS Malignancy Consortium (AMC) trial.
    Cianfrocca M; Lee S; Von Roenn J; Rudek MA; Dezube BJ; Krown SE; Sparano JA
    Cancer Chemother Pharmacol; 2011 Oct; 68(4):827-33. PubMed ID: 21207228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and associated risk factors for Kaposi's sarcoma among HIV-positive patients in a referral hospital in Northern Tanzania: a retrospective hospital-based study.
    Semango GP; Charles RM; Swai CI; Mremi A; Amsi P; Sonda T; Shao ER; Mavura DR; Joosten LAB; Sauli E; Nyindo M
    BMC Cancer; 2018 Dec; 18(1):1258. PubMed ID: 30558571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kaposi's sarcoma in HIV infected women in Germany: more evidence for sexual transmission. A report of 10 cases and review of the literature.
    Albrecht H; Helm EB; Plettenberg A; Emminger C; Heise W; Schwartländer B; Stellbrink HJ
    Genitourin Med; 1994 Dec; 70(6):394-8. PubMed ID: 7705856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study.
    Gill PS; Espina BM; Moudgil T; Kidane S; Esplin JA; Tulpule A; Levine AM
    Leukemia; 1994; 8 Suppl 3():S26-32. PubMed ID: 7808021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy.
    Jones JL; Hanson DL; Dworkin MS; Jaffe HW
    J Acquir Immune Defic Syndr; 2000 Jul; 24(3):270-4. PubMed ID: 10969352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiological and Clinical Patterns of Kaposi Sarcoma: A 16-Year Retrospective Cross-Sectional Study from Yaoundé, Cameroon.
    Tounouga DN; Kouotou EA; Nansseu JR; Zoung-Kanyi Bissek AC
    Dermatology; 2018; 234(5-6):198-204. PubMed ID: 30205412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma.
    Whitby D; Howard MR; Tenant-Flowers M; Brink NS; Copas A; Boshoff C; Hatzioannou T; Suggett FE; Aldam DM; Denton AS
    Lancet; 1995 Sep; 346(8978):799-802. PubMed ID: 7674745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kaposi's sarcoma in HIV-infected women and men in Nigeria.
    Ibekwe PU; Ogunbiyi OA; Ogun GO; George OA
    AIDS Patient Care STDS; 2011 Nov; 25(11):635-7. PubMed ID: 21967494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin 6 and AIDS-associated Kaposi's sarcoma: a nested case control study within the Multicenter AIDS Cohort Study.
    Dourado I; Martínez-Maza O; Kishimoto T; Suzuki H; Detels R
    AIDS Res Hum Retroviruses; 1997 Jun; 13(9):781-8. PubMed ID: 9171222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery.
    Lichterfeld M; Qurishi N; Hoffmann C; Hochdorfer B; Brockmeyer NH; Arasteh K; Mauss S; Rockstroh JK;
    Infection; 2005 Jun; 33(3):140-7. PubMed ID: 15940415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kaposi's sarcoma: a reevaluation.
    Orfanos CE; Husak R; Wölfer U; Garbe C
    Recent Results Cancer Res; 1995; 139():275-96. PubMed ID: 7541146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy.
    Cattelan AM; Calabrò ML; De Rossi A; Aversa SM; Barbierato M; Trevenzoli M; Gasperini P; Zanchetta M; Cadrobbi P; Monfardini S; Chieco-Bianchi L
    Int J Oncol; 2005 Sep; 27(3):779-85. PubMed ID: 16077928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The clinico-pathogenetic characteristics of Kaposi's sarcoma].
    Rytik PG; Khmara ME; Protas II; Nedz'ved' MK
    Klin Med (Mosk); 1992 Jan; 70(1):19-23. PubMed ID: 1608201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.